Verastem (VSTM) FCF Margin (2018 - 2026)
Verastem's (VSTM) quarterly FCF Margin came in at 279.13% in Q1 2026, down 63.4% quarter-over-quarter from 170.82% in Q4 2025.
Verastem (VSTM) FCF Margin (2018 - 2026) Analysis & Trends
Verastem's FCF Margin history runs 8 years deep, the most recent figure standing at 279.13% for Q1 2026.
- On a quarterly basis, FCF Margin changed N/A year-over-year to 279.13% in Q1 2026; TTM through Mar 2026 was 304.42%, a N/A change from a year earlier, with the FY2025 full-year figure at 444.81%, up 60318.0% from the prior year.
- FCF Margin declined to 279.13% in Q1 2026 per VSTM's latest filing, from 170.82% in the prior quarter.
- Across five years, FCF Margin topped out at 170.82% in Q4 2025 and bottomed at 1528.45% in Q2 2025.
- The 4-year median for FCF Margin is 300.64% (2026), against an average of 553.2%.
- Across the five-year window, FCF Margin surged 119704 bps in 2022 and sank 125254 bps in 2025, its largest moves.
- Year by year, FCF Margin stood at 742.72% in 2022, then surged by 63 bps to 275.91% in 2024, then soared by 38 bps to 170.82% in 2025, then sank by 63 bps to 279.13% in 2026.
- Per Business Quant, the three latest VSTM FCF Margin figures stand at 279.13% (Q1 2026), 170.82% (Q4 2025), and 322.15% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | -279.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -279.13% |
| Dec 31, 2025 | -170.82% |
| Sep 30, 2025 | -322.15% |
| Jun 30, 2025 | -1,528.45% |
| Jun 30, 2024 | -275.91% |
| Mar 31, 2022 | -742.72% |
| Dec 31, 2021 | -1,822.57% |
| Sep 30, 2021 | -541,350.00% |
| Jun 30, 2021 | -2,684.80% |
| Mar 31, 2021 | -1,939.76% |
| Dec 31, 2020 | -4,289.13% |
| Sep 30, 2020 | 56.86% |
| Jun 30, 2020 | -523.33% |
| Mar 31, 2020 | -672.78% |
| Dec 31, 2019 | -1,029.06% |
| Sep 30, 2019 | -308.33% |
| Jun 30, 2019 | -1,105.52% |
| Mar 31, 2019 | -2,320.77% |
| Dec 31, 2018 | -1,607.52% |
| Sep 30, 2018 | -149.13% |